Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,439 | -40,132 | -26,874 | -11,914 | -44,596 |
| Depreciation Amortization | -883 | 144 | 179 | -83 | -353 |
| Other Working Capital | -1,860 | -2,210 | -2,004 | -3,549 | 5,016 |
| Other Operating Activity | 3,817 | 2,783 | 1,736 | 833 | 4,125 |
| Operating Cash Flow | $-56,365 | $-39,415 | $-26,963 | $-14,713 | $-35,808 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -204,631 | N/A | N/A | N/A | -29,382 |
| PPE Investments | -94 | -70 | -66 | -44 | -63 |
| Purchase Of Investment | N/A | -141,923 | -117,511 | -65,810 | N/A |
| Sale Of Investment | 65,234 | 29,410 | 11,500 | 7,500 | 48,600 |
| Investing Cash Flow | $-139,491 | $-112,583 | $-106,077 | $-58,354 | $19,155 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 41,964 |
| Common Stock Issued | 2,550 | 2,550 | 2,537 | 1 | 97,984 |
| Other Financing Activity | 80,165 | -799 | -799 | 1,729 | -83 |
| Financing Cash Flow | $82,715 | $1,751 | $1,738 | $1,730 | $139,865 |
| Beginning Cash Position | 163,543 | 163,543 | 163,543 | 163,543 | 40,331 |
| End Cash Position | 50,402 | 13,296 | 32,241 | 92,206 | 163,543 |
| Net Cash Flow | $-113,141 | $-150,247 | $-131,302 | $-71,337 | $123,212 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,365 | -39,415 | -26,963 | -14,713 | -35,808 |
| Capital Expenditure | -94 | -70 | -66 | -44 | -63 |
| Free Cash Flow | -56,459 | -39,485 | -27,029 | -14,757 | -35,871 |